VARDIX has expanded its product portfolio with the addition of Lonevi — an intelligent longevity platform that uses artificial intelligence to help people live longer, healthier lives through data-driven personalization.
The platform is now accessible through VARDIX and is live at lonevi.com.
What Is Lonevi
Lonevi moves beyond generic health advice. Instead of population-average recommendations, it builds a biological baseline unique to each user — integrating genetic data, lab biomarkers, wearable device readings, sleep patterns, nutrition habits, and environmental factors into a single coherent picture.
The AI engine continuously updates a personalized longevity roadmap as new data comes in. It doesn't just track metrics — it surfaces specific, ranked interventions based on what the science and your individual biology say will actually move the needle.
Key capabilities:
- Genetic & Biomarker Analysis — builds a biological baseline from lab results and genetic data, not population averages
- AI Personalization Engine — updates your roadmap as data changes: lab results, lifestyle shifts, wearable readings
- Longevity Score — tracks biological age versus chronological age over time, with intervention impact measurement
- Preventive Medicine Focus — flags risks before symptoms appear: biomarker shifts, deficiency patterns, inflammation markers
- Lab & Wearable Integration — connects Apple Health, Garmin, Whoop, Oura Ring, and lab providers into one view
The Problem It Solves
Most longevity programs give everyone the same advice. The same diet, the same supplement stack, the same sleep targets — regardless of what your genes or biomarkers actually say. This approach produces average results at best.
Lonevi is built on a different premise: lasting health improvement requires personalization at the molecular level. Your biology is different from everyone else's, and your interventions should reflect that.
The platform targets the gap between what modern longevity science knows is possible and what individuals can actually act on with the tools available today.
Why This Matters for Our Market
The global longevity technology market is accelerating. Consumer interest in biological age tracking, preventive health, and evidence-based supplementation has crossed from early adopters into mainstream demand — driven by an expanding base of wearable users, routine lab testing adoption, and growing awareness of genetic screening.
Kazakhstan and Central Asia sit at an inflection point in healthcare technology adoption. Institutional health systems are modernizing. Private healthcare spending is increasing. The conditions for precision health tools to find a real market exist — and the demand for scientifically credible, personalized approaches is there.
For VARDIX, Lonevi complements our existing healthcare and education portfolio — including VARGATES Medical — and reinforces our direction toward technology that creates measurable, evidence-backed outcomes rather than software for its own sake.
Access
Lonevi is available directly at lonevi.com. The platform supports individual users and is developing enterprise and clinical partnership programs for healthcare providers, corporate wellness programs, and research institutions.
For inquiries about integration, enterprise access, or partnership in Kazakhstan and Central Asia, contact VARDIX through the contact page.